Cite
Risk factors for hepatocellular carcinoma in hepatitis C patients with normal alanine aminotransferase treated with pegylated interferon and ribavirin.
MLA
Harada, N., et al. “Risk Factors for Hepatocellular Carcinoma in Hepatitis C Patients with Normal Alanine Aminotransferase Treated with Pegylated Interferon and Ribavirin.” Journal of Viral Hepatitis, vol. 21, no. 5, May 2014, pp. 357–65. EBSCOhost, https://doi.org/10.1111/jvh.12151.
APA
Harada, N., Hiramatsu, N., Oze, T., Morishita, N., Yamada, R., Hikita, H., Miyazaki, M., Yakushijin, T., Miyagi, T., Yoshida, Y., Tatsumi, T., Kanto, T., Kasahara, A., Oshita, M., Mita, E., Hagiwara, H., Inui, Y., Katayama, K., Tamura, S., & Yoshihara, H. (2014). Risk factors for hepatocellular carcinoma in hepatitis C patients with normal alanine aminotransferase treated with pegylated interferon and ribavirin. Journal of Viral Hepatitis, 21(5), 357–365. https://doi.org/10.1111/jvh.12151
Chicago
Harada, N., N. Hiramatsu, T. Oze, N. Morishita, R. Yamada, H. Hikita, M. Miyazaki, et al. 2014. “Risk Factors for Hepatocellular Carcinoma in Hepatitis C Patients with Normal Alanine Aminotransferase Treated with Pegylated Interferon and Ribavirin.” Journal of Viral Hepatitis 21 (5): 357–65. doi:10.1111/jvh.12151.